BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Curis, Inc. 

61 Moulton Street

Cambridge  Massachusetts  02138  U.S.A.
Phone: 617-876-0086 Fax: 617-876-0866


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Curis, Inc. (CRIS) To Present At The 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 10/3/2014 7:10:41 AM
Curis, Inc. (CRIS) Announces CUDC-907 Development Program Advancements 10/2/2014 8:04:10 AM
Curis, Inc. (CRIS) To Present At Upcoming Investor Conference 8/27/2014 8:33:10 AM
Curis, Inc. (CRIS) Reports Second Quarter 2014 Financial Results 8/7/2014 8:06:15 AM
Curis, Inc. (CRIS) To Release Second Quarter 2014 Financial Results And Hold Conference Call On August 7, 2014 7/31/2014 10:18:25 AM
Curis, Inc. (CRIS) Announces Investigational New Drug Application Filing By Roche (RHHBY) To Initiate A Phase 2 Study Of Erivedge® (Vismodegib) In Idiopathic Pulmonary Fibrosis 6/23/2014 7:47:43 AM
Curis, Inc. (CRIS) To Present At The JMP Securities Healthcare Conference 6/18/2014 8:34:37 AM
Curis, Inc. (CRIS) Announces Re-Initiation Of Patient Dosing In CUDC-427 Monotherapy Clinical Trial 6/5/2014 9:27:25 AM
Curis, Inc. (CRIS) Appoints A New CEO 6/3/2014 9:13:09 AM
Curis, Inc. (CRIS) To Present At The Jefferies and Co. 2014 Global Healthcare Conference 5/29/2014 9:38:35 AM
12345678910...